First Trust Advisors LP Novo Nordisk A S Transaction History

First Trust Advisors LP

  • $95 Billion
  • Q2 2024

A detailed history of First Trust Advisors LP transactions in Novo Nordisk A S stock. As of the latest transaction made, First Trust Advisors LP holds 392,420 shares of NVO stock, worth $46.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
392,420
Previous 512,232 23.39%
Holding current value
$46.7 Million
Previous $65.8 Million 14.83%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$122.71 - $146.91 $14.7 Million - $17.6 Million
-119,812 Reduced 23.39%
392,420 $56 Million
Q1 2024

May 13, 2024
BUY
$102.11 - $135.92 $45.1 Million - $60 Million
441,343 Added 622.58%
512,232 $65.8 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $7.13 Million - $8.57 Million
-81,256 Reduced 53.41%
70,889 $7.33 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $7.26 Million - $15.9 Million
79,878 Added 110.53%
152,145 $13.8 Million
Q2 2023

Aug 14, 2023
SELL
$155.98 - $172.65 $12.1 Million - $13.3 Million
-77,275 Reduced 51.67%
72,267 $11.7 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $12.2 Million - $14.7 Million
92,404 Added 161.72%
149,542 $23.8 Million
Q4 2022

Feb 09, 2023
SELL
$102.55 - $135.33 $62.8 Million - $82.9 Million
-612,616 Reduced 91.47%
57,138 $7.73 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $63.6 Million - $78.1 Million
667,905 Added 36122.5%
669,754 $66.7 Million
Q2 2022

Aug 12, 2022
SELL
$103.24 - $121.81 $57.3 Million - $67.6 Million
-554,905 Reduced 99.67%
1,849 $206,000
Q1 2022

May 13, 2022
SELL
$93.1 - $112.54 $103,341 - $124,919
-1,110 Reduced 0.2%
556,754 $61.8 Million
Q4 2021

Feb 08, 2022
SELL
$95.88 - $117.08 $3.33 Million - $4.06 Million
-34,683 Reduced 5.85%
557,864 $62.5 Million
Q3 2021

Nov 15, 2021
SELL
$84.42 - $106.62 $10.6 Million - $13.4 Million
-125,666 Reduced 17.5%
592,547 $56.9 Million
Q2 2021

Oct 12, 2021
BUY
$67.66 - $84.76 $42,355 - $53,059
626 Added 0.09%
718,213 $60.1 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $7.24 Million - $9.07 Million
-107,052 Reduced 12.98%
717,587 $60.1 Million
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $4.67 Million - $5.28 Million
69,649 Added 9.23%
824,639 $55.6 Million
Q4 2020

Feb 02, 2021
SELL
$63.89 - $73.8 $887,943 - $1.03 Million
-13,898 Reduced 1.81%
754,990 $52.7 Million
Q3 2020

Nov 05, 2020
BUY
$63.69 - $70.22 $5.36 Million - $5.91 Million
84,219 Added 12.3%
768,888 $53.4 Million
Q2 2020

Jul 22, 2020
BUY
$58.54 - $67.94 $851,405 - $988,119
14,544 Added 2.17%
684,669 $44.8 Million
Q1 2020

May 06, 2020
SELL
$49.46 - $64.78 $8.19 Million - $10.7 Million
-165,624 Reduced 19.82%
670,125 $40.3 Million
Q4 2019

Feb 03, 2020
BUY
$49.86 - $58.26 $41.5 Million - $48.5 Million
831,849 Added 21329.46%
835,749 $48.4 Million
Q3 2019

Nov 04, 2019
SELL
$47.54 - $53.43 $16,068 - $18,059
-338 Reduced 7.98%
3,900 $202,000
Q2 2019

Jul 30, 2019
BUY
$46.79 - $52.47 $198,296 - $222,367
4,238 New
4,238 $216,000
Q1 2019

May 09, 2019
SELL
$46.36 - $52.63 $942,637 - $1.07 Million
-20,333 Closed
0 $0
Q4 2018

Feb 07, 2019
SELL
$41.54 - $47.25 $20.4 Million - $23.2 Million
-490,435 Reduced 96.02%
20,333 $937,000
Q3 2018

Oct 25, 2018
BUY
$46.76 - $51.24 $2.06 Million - $2.26 Million
44,137 Added 9.46%
510,768 $24.1 Million
Q2 2018

Aug 02, 2018
BUY
$44.29 - $50.42 $20.2 Million - $23 Million
456,983 Added 4736.56%
466,631 $21.5 Million
Q1 2018

Apr 23, 2018
SELL
$48.49 - $58.14 $932,268 - $1.12 Million
-19,226 Reduced 66.59%
9,648 $475,000
Q4 2017

Feb 08, 2018
BUY
$47.53 - $53.73 $486,136 - $549,550
10,228 Added 54.85%
28,874 $1.55 Million
Q3 2017

Oct 24, 2017
BUY
$41.15 - $49.22 $767,282 - $917,756
18,646
18,646 $898,000

Others Institutions Holding NVO

# of Institutions
1,991
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email